ARGX · NASDAQ · STOCK
argenx SE (ARGX) Stock Analysis
$848.74
52W $661.85 – $1072.75
59/100
$50.47B
29.1
-0.02
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is ARGX Bullish or Bearish?
Bullish.
Innellis AI committee rates argenx SE (ARGX) Buy with a composite score of 59/100
, based on 6 analysts with 50% agreement.
Last updated October 14, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +15.58 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -4.42 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 165.2% yoy -- genuine top-line momentum. Portfolio Manager remains cautious — sector concentration is already high (hhi 2802.55). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 22.4% shows genuine earnings power backing the valuation — Value
- Revenue growing 165.2% YoY -- genuine top-line momentum — Growth
- EPS growing 95.7% YoY — Growth
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Low leverage (debt-to-equity 0.01) -- balance sheet can absorb a shock — Risk
Bear Case
- Price-to-book of 6.7x prices in significant intangible value — Value
- RSI at 15 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 27.3% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 14, 2026
Overall Committee Score
59/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 36%
of 192 Healthcare peers
Value Analyst
neutral
59
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 22.4% shows genuine earnings power backing the valuation
− Price-to-book of 6.7x prices in significant intangible value
Growth Analyst
bullish
84
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 165.2% YoY -- genuine top-line momentum
Technical Analyst
bearish
38
/ 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− RSI at 15 is in oversold territory (could mean either capitulation or a bounce setup)
Risk Analyst
neutral
58
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.01) -- balance sheet can absorb a shock
− Bollinger bandwidth of 27.3% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
53
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2802.55)
Investment Thesis Evolution
Committee score moved marginally from 61.9 to 59.4.
- New bearish signals: 3 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- Bearish pressure eased: 4 signal(s) disappeared.
Analyst-level changes:
- Macro Analyst: score 80->65 (-15).
- Portfolio Manager: +1 bearish signal(s).
- Risk Analyst: +1 bearish signal(s).
- Technical Analyst: +1 bearish signal(s).
Comparing 2026-10-13 to 2026-10-14 (1 day apart).
Technical Analysis
RSI (14)
24.4
Oversold
MACD Histogram
-15.635
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$771.39
Resistance
$851.86
Bollinger %B
0.11
Inside Bands
Price vs Moving Averages
EMA 9
$855.28
Below
EMA 21
$903.52
Below
EMA 50
$927.32
Below
EMA 200
$866.19
Below
Fundamental Analysis
Valuation
59
Growth
88
Profitability
97
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
29.1×
P/B Ratio
5.92×
PEG Ratio
0.08
Dividend Yield
0.00%
52W High
$1072.75
52W Low
$661.85
Quality & Growth
ROE
1764.3%
ROA
1488.1%
Gross Margin
8994.2%
Operating Margin
2880.6%
Revenue Growth YoY
—
Debt / Equity
0.01
AI Fundamental Assessment
P/E ratio of 29.1 (moderate relative to a 15-40x range); Price-to-book of 5.9x; PEG ratio of 0.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 17.6%; Return on assets of 14.9%; Net margin of 32.9%; Gross margin of 89.9%; Current ratio of 5.12 (healthy short-term liquidity); Debt-to-equity of 0.01; Free cash flow per share is positive (18.00); Most recent quarter beat estimates by 16.5%; 4 consecutive earnings beats; EPS growth accelerating (-31.2% -> +32.8% QoQ); Analyst estimates flat over recent quarters
Get the Full ARGX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →